Bruker Corporation BRKR
$60.52
-4.00%
at last close
Market Cap$9.61 billion
P/E Ratio—
Div Yield0.33%
Volume1.13M
52-Week Range
$28.53$65.30
Analyst Ratings
- Consensus
- Moderate Buy — 7 Buy · 4 Hold · 1 Sell (12 analysts)
- Avg. Price Target
- $58.00 (-4.2% downside)
Key Stats
- Today's Range
- $60.40 – $63.49
- 50-Day Range
- $48.63 – $65.30
- 52-Week Range
- $28.53 – $65.30
- Volume
- 1.13 million shs
- Average Volume
- 2.06 million shs
- Market Cap
- $9.61 billion
- P/E Ratio
- —
- Dividend Yield
- 0.33%
Valuation
- P/E Ratio
- —
- Price / Book
- 4.00
- Price / Sales
- 2.74
Dividend
- Dividend Yield
- 0.33%
- Annual Dividend
- $0.20
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-09-21
Short Interest
- Short Interest
- 1.53%
- Days to Cover
- 6.02
Financials (TTM)
- Revenue
- $3.50 billion
- Net Income
- $-64,500,000
- Net Margin
- -1.84%
- Return on Equity
- -2.69%
- Debt-to-Equity
- 0.76
About Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Related Stocks
Compare head-to-head: BRKR vs WAT·BRKR vs BIO·BRKR vs TXG·BRKR vs CTKB
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.